TY - BOOK ID - 1523009 TI - The public financing of pharmaceuticals : an economic approach. PY - 2005 SN - 1845420888 PB - Cheltenham Elgar DB - UniCat KW - Industrial economics KW - Public expenditure KW - Analysis of pharmaceuticals KW - Toxicology KW - Pharmaceutical industry KW - Drugs KW - Government policy KW - Finance. KW - Research KW - Drug Industry KW - Financing, Government. KW - AA / International- internationaal KW - 338.754.12 KW - 336.024 KW - 368.40 KW - financiƫn, overheid KW - geneesmiddelen KW - pharmacie KW - prijsbeleid KW - prijsvorming KW - sociale zekerheid KW - Government Financing KW - Federal Aid KW - Financing, Public KW - Grants and Subsidies, Government KW - Hill-Burton Act KW - Subsidies, Government KW - Act, Hill-Burton KW - Aid, Federal KW - Aids, Federal KW - Federal Aids KW - Government Subsidies KW - Government Subsidy KW - Hill Burton Act KW - Public Financing KW - Subsidy, Government KW - economics KW - Farmaceutische producten en parfumerie. KW - Sociale begroting, rekeningen en uitgaven. Gezondheid. KW - Sociale voorzorg en verzekeringen. Sociale zekerheid: algemeenheden. KW - Financing, Government KW - Drug industry KW - Drug trade KW - Medicine industry KW - Medicines industry KW - Prescription medicine industry KW - Chemical industry KW - Medicaments KW - Medications KW - Medicine (Drugs) KW - Medicines (Drugs) KW - Pharmaceuticals KW - Prescription drugs KW - Bioactive compounds KW - Medical supplies KW - Pharmacopoeias KW - Chemotherapy KW - Materia medica KW - Pharmacology KW - Pharmacy KW - Research&delete& KW - Finance KW - Sociale begroting, rekeningen en uitgaven. Gezondheid KW - Farmaceutische producten en parfumerie KW - Sociale voorzorg en verzekeringen. Sociale zekerheid: algemeenheden UR - https://www.unicat.be/uniCat?func=search&query=sysid:1523009 AB - PART I: Incentives for innovation in the pharmaceutical market - Price regulations systems in the pharmaceutical market - Regulation and competition in pharmaceutical markets - Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare - PART II: Reference pricing as a pharmaceutical reimbursement mechanism - Insurance in public financing of pharmaceuticals - Economic evaluation and pharmaceutical policy - Prescriber incentives - PART III: Economic considerations regarding pharmaceutical expenditure in Spain and its financing - Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanisch economists ER -